Clinical Trials List
Protocol Number106372 (FLU NG-006 PRI)
2008-09-01 - 2010-12-31
Phase III
Terminated2
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Shan-Chwen Chang Division of Infectious Disease
- Chong-Jen Yu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 劉瑞瑤 Division of Family Medicine
- 林明憲 Division of Family Medicine
- 林宜璁 Division of Family Medicine
- Fu-Der Wang Division of Infectious Disease
- 賴秀昀 Division of Family Medicine
- Tzeng-Ji Chen Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2,000 participants
-
Global
43,614 participants
